Globalization: a new dimension for academic internal medicine.

PubWeight™: 1.50‹?› | Rank: Top 4%

🔗 View Article (PMID 16945620)

Published in Am J Med on September 01, 2006

Authors

Jonathan I Ravdin1, Phillip K Peterson, Edward Wing, Tod Ibrahim, Merle A Sande

Author Affiliations

1: Department of Medicine, University of Minnesota, Minneapolis 55455, USA. ravdi001@umn.edu

Articles by these authors

Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis (2005) 12.59

Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis (2008) 3.91

Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev (2008) 2.88

Role of microglia in central nervous system infections. Clin Microbiol Rev (2004) 2.69

Part-time careers in academic internal medicine: a report from the association of specialty professors part-time careers task force on behalf of the alliance for academic internal medicine. Acad Med (2009) 1.82

Recruiting the next generation of nephrologists. Adv Chronic Kidney Dis (2013) 1.74

Morphine induces apoptosis of human microglia and neurons. Neuropharmacology (2002) 1.61

The impact of increasing medical school class size on clinical clerkships: a national survey of internal medicine clerkship directors. Acad Med (2008) 1.55

The future nephrology workforce: will there be one? Clin J Am Soc Nephrol (2011) 1.53

Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia (2005) 1.49

Opioid G protein-coupled receptors: signals at the crossroads of inflammation. Trends Immunol (2003) 1.45

Confronting the brutal facts in health care. Am J Med (2005) 1.39

ASN policy on managing conflicts of interest. J Am Soc Nephrol (2009) 1.39

Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations. Am J Epidemiol (2005) 1.31

Toll-like receptors in defense and damage of the central nervous system. J Neuroimmune Pharmacol (2007) 1.24

Microglia as a pharmacological target in infectious and inflammatory diseases of the brain. J Neuroimmune Pharmacol (2006) 1.23

Morphine potentiates HIV-1 gp120-induced neuronal apoptosis. J Infect Dis (2005) 1.20

Differential responses of human brain cells to West Nile virus infection. J Neurovirol (2005) 1.17

Mycobacterium tuberculosis-induced cytokine and chemokine expression by human microglia and astrocytes: effects of dexamethasone. J Infect Dis (2005) 1.17

TNF-alpha-induced chemokine production and apoptosis in human neural precursor cells. J Leukoc Biol (2005) 1.14

The medical management of central nervous system infections in Uganda and the potential impact of an algorithm-based approach to improve outcomes. Int J Infect Dis (2007) 1.10

High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells. Brain Res Dev Brain Res (2004) 1.09

Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1. Int Immunopharmacol (2006) 1.08

CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. J Virol (2003) 1.08

Neural precursor cell susceptibility to human cytomegalovirus diverges along glial or neuronal differentiation pathways. J Neurosci Res (2005) 1.07

Early detection of central nervous system tuberculosis with the gen-probe nucleic Acid amplification assay: utility in an inner city hospital. Clin Infect Dis (2002) 1.05

Training needs assessment for clinicians at antiretroviral therapy clinics: evidence from a national survey in Uganda. Hum Resour Health (2009) 1.05

Serial testing of refugees for latent tuberculosis using the QuantiFERON-gold in-tube: effects of an antecedent tuberculin skin test. Am J Trop Med Hyg (2009) 1.03

Measuring the outcomes of a comprehensive HIV care course: pilot test at the Infectious Diseases Institute, Kampala, Uganda. J Acquir Immune Defic Syndr (2006) 1.01

Cocaine alters proliferation, migration, and differentiation of human fetal brain-derived neural precursor cells. J Pharmacol Exp Ther (2006) 1.01

Antimicrobial resistance in Escherichia coli causing urinary tract infections in Costa Rica: a clinical dilemma. Int J Antimicrob Agents (2003) 0.98

WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors. J Neuroimmune Pharmacol (2006) 0.96

Influenza, Winter Olympiad, 2002. Emerg Infect Dis (2006) 0.95

The feasibility and acceptability of implementing formal evaluation sessions and using descriptive vocabulary to assess student performance on a clinical clerkship. Teach Learn Med (2002) 0.94

U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes. Biochem Pharmacol (2003) 0.93

Morphine stimulates CCL2 production by human neurons. J Neuroinflammation (2006) 0.92

Glial cell responses to herpesvirus infections: role in defense and immunopathogenesis. J Infect Dis (2002) 0.90

Kappa-opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4(+) lymphocytes. Biochem Pharmacol (2002) 0.90

Treatment of HIV/AIDS: do the dilemmas only increase? JAMA (2004) 0.89

Clinical presentation and aetiologies of acute or complicated headache among HIV-seropositive patients in a Ugandan clinic. J Int AIDS Soc (2009) 0.88

Anti-HIV-1 activity of propolis in CD4(+) lymphocyte and microglial cell cultures. J Ethnopharmacol (2005) 0.88

Kappa-opioid receptor ligands inhibit cocaine-induced HIV-1 expression in microglial cells. J Pharmacol Exp Ther (2004) 0.88

Potentiation of HIV-1 expression in microglial cells by nicotine: involvement of transforming growth factor-beta 1. J Neuroimmune Pharmacol (2007) 0.87

Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage. J Neurovirol (2009) 0.86

HIV/AIDS care in Africa today. Clin Infect Dis (2005) 0.83

Abdominal aortitis due to Streptococcus pneumoniae and Enterobacter aerogenes: a case report and review. J Gen Intern Med (2006) 0.83

Morphine modulates gammadelta lymphocytes cytolytic activity following BCG vaccination. Brain Behav Immun (2006) 0.82

Turnover among APM members since 1971. Am J Med (2002) 0.81

Lessons from Haiti on disaster relief. Clin J Am Soc Nephrol (2010) 0.80

Postgraduate training in infectious diseases. Lancet Infect Dis (2006) 0.79

Role of nitric oxide in defense of the central nervous system against Mycobacterium tuberculosis. J Infect Dis (2008) 0.79

Changes in the NMR metabolic profile of human microglial cells exposed to lipopolysaccharide or morphine. J Neuroimmune Pharmacol (2010) 0.76

Human neural precursor cells express functional kappa-opioid receptors. J Pharmacol Exp Ther (2007) 0.76

Emerging resistance to nonnucleoside reverse transcriptase inhibitors: a warning and a challenge. JAMA (2002) 0.75

The case for invigorating internal medicine. Am J Med (2004) 0.75

Helping nephrologists become lifelong learners. Clin J Am Soc Nephrol (2008) 0.75

Centers, institutes, and the future of clinical departments: Part II. Am J Med (2003) 0.75

Tenures for department chairs: how short is too short? Am J Med (2008) 0.75

Centers, Institutes, and the future of clinical departments: part I. Am J Med (2003) 0.75